Genmab A/S (GMAB)
27.72
-1.00
(-3.48%)
USD |
NASDAQ |
May 02, 16:00
27.72
0.00 (0.00%)
After-Hours: 16:09
Genmab Market Cap: 18.09B for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 18.74B |
| April 30, 2024 | 18.07B |
| April 29, 2024 | 18.64B |
| April 26, 2024 | 18.37B |
| April 25, 2024 | 17.92B |
| April 24, 2024 | 18.57B |
| April 23, 2024 | 18.63B |
| April 22, 2024 | 18.90B |
| April 19, 2024 | 18.73B |
| April 18, 2024 | 18.48B |
| April 17, 2024 | 18.61B |
| April 16, 2024 | 19.20B |
| April 15, 2024 | 19.25B |
| April 12, 2024 | 19.09B |
| April 11, 2024 | 19.40B |
| April 10, 2024 | 19.54B |
| April 09, 2024 | 19.55B |
| April 08, 2024 | 19.48B |
| April 05, 2024 | 19.42B |
| April 04, 2024 | 19.34B |
| April 03, 2024 | 19.12B |
| April 02, 2024 | 19.55B |
| April 01, 2024 | 19.75B |
| March 28, 2024 | 19.51B |
| March 27, 2024 | 19.98B |
| Date | Value |
|---|---|
| March 26, 2024 | 20.11B |
| March 25, 2024 | 19.56B |
| March 22, 2024 | 19.52B |
| March 21, 2024 | 19.29B |
| March 20, 2024 | 19.21B |
| March 19, 2024 | 19.34B |
| March 18, 2024 | 19.37B |
| March 15, 2024 | 19.53B |
| March 14, 2024 | 19.77B |
| March 13, 2024 | 20.45B |
| March 12, 2024 | 20.51B |
| March 11, 2024 | 20.67B |
| March 08, 2024 | 19.77B |
| March 07, 2024 | 19.19B |
| March 06, 2024 | 18.83B |
| March 05, 2024 | 18.76B |
| March 04, 2024 | 18.60B |
| March 01, 2024 | 19.11B |
| February 29, 2024 | 18.13B |
| February 28, 2024 | 18.07B |
| February 27, 2024 | 18.97B |
| February 26, 2024 | 19.18B |
| February 23, 2024 | 19.03B |
| February 22, 2024 | 19.01B |
| February 21, 2024 | 18.91B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.07B
Minimum
May 13 2019
31.85B
Maximum
Sep 03 2021
21.82B
Average
23.06B
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 7.999B |
| Novo Nordisk A/S | 553.16B |
| Galecto Inc | 19.32M |
| Evaxion Biotech AS | 20.96M |
| IO Biotech Inc | 100.80M |
Market Cap Related Metrics
| PE Ratio | 28.81 |
| PS Ratio | 7.637 |
| Price to Book Value | 3.854 |
| Price to Free Cash Flow | 17.97 |
| Price | 27.72 |
| Earnings Yield | 3.47% |
| Operating PE Ratio | 23.63 |
| Normalized PE Ratio | 26.63 |